Young Cancer Patients Sleep Worse Than Healthy Peers, Major Study Finds

Sleep is one of the most undervalued vital signs in medicine, and a new study suggests that for adolescents and young adults diagnosed with cancer, it may be quietly eroding at exactly the age when the brain, body, and social life depend on it most. A large prospective observational study from Germany, known as the AYA-LE study, has found that cancer patients between the ages of 18 and 39 sleep measurably worse than their healthy peers across nearly every dimension that sleep researchers track, from how long it takes them to drift off to how wrecked they feel the next day. The findings, published in the Journal of Cancer Research and Clinical Oncology, add a crucial piece of evidence to a question that has divided the psycho-oncology field for years: does cancer itself, in this uniquely vulnerable age group, actually damage sleep?

The scientific stakes are higher than they might first appear. Adolescents and young adults, often abbreviated as AYAs in oncology, occupy an awkward middle ground in cancer care. They are too old for most pediatric protocols and too young for the geriatric pathways that dominate adult oncology, and their survival rates have historically improved more slowly than those of either children or older adults. Previous research has shown that AYA cancer patients tend to engage in riskier health behaviors than older patients, including smoking, physical inactivity, and poor sleep habits. But when researchers tried to pin down whether AYA patients sleep worse specifically because of cancer, the literature turned contradictory. Some studies reported dramatically elevated rates of insomnia in young survivors; others found sleep quality roughly comparable to that of the general population. The inconsistency left clinicians without a clear mandate to screen for sleep problems in this group.

To resolve the question, a team led by Carolin Wieland of the Department of Medical Psychology and Medical Sociology at the Comprehensive Cancer Center Central Germany, University Medical Center Leipzig, recruited 407 AYA cancer patients aged 18 to 39 at diagnosis and compared them with 372 healthy participants aged 18 to 45. Data were collected between May and September 2019. The patients had a mean age of 34.8 years and were predominantly female, at 75.2 percent, while the healthy comparison group averaged 32.3 years of age and was 61.8 percent female. The design is notable for what it avoided: rather than comparing patients against published population norms, which can drift over time and across cultures, the researchers built a matched healthy comparison group and measured both groups with the same instruments during the same window.

The central measuring stick was the Pittsburgh Sleep Quality Index, or PSQI, a validated questionnaire that has become the de facto international standard for assessing subjective sleep over the preceding month. The PSQI does not merely ask whether someone sleeps badly; it decomposes sleep into seven component scores, covering subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. This decomposition matters clinically, because two patients with identical total scores can have entirely different problems, one lying awake for hours and another sleeping a full eight hours yet waking exhausted. By analyzing the components separately, the Leipzig team could see precisely where the cancer patients’ sleep broke down.

The answer was: almost everywhere, but modestly and consistently. AYA cancer patients reported significantly poorer subjective sleep quality, with an effect size of d equal to 0.31, along with lower sleep efficiency at d equal to 0.15, more frequent sleep disturbances at d equal to 0.23, greater use of sleep medication at d equal to 0.25, and higher daytime dysfunction at d equal to 0.29. In the language of behavioral statistics, these are small to moderate effect sizes, which is precisely why the field has struggled. No single number screams for attention, yet the pattern is coherent and spans five of the seven PSQI components. Patients did not merely feel that their sleep was worse; they were also less efficient sleepers, more often medicated, and more functionally impaired during the day. Daytime dysfunction, the component most tightly linked to quality of life, fatigue, and cognitive performance at work or in education, showed one of the largest gaps between the groups.

Perhaps more revealing than the group comparison is what the regression analyses uncovered about who sleeps worst within the patient group. Using multiple regression, the researchers tested a battery of sociodemographic, clinical, and psychosocial variables measured with validated instruments: general self-efficacy, social support, anxiety and depression assessed with the Hospital Anxiety and Depression Scale, quality of life measured with the EORTC questionnaires, unmet supportive care needs captured by the Supportive Care Needs Survey, lack of energy, and physical activity. The model explained a substantial share of the variance in sleep quality, with an adjusted R-squared of 0.35, and three psychological variables stood out. Anxiety, depression, and unmet needs related to lack of energy were all significantly associated with worse PSQI scores, alongside reduced quality of life.

This triangulation of sleep with mood and energy is not a statistical accident, sleep scientists argue, but a reflection of shared biology and shared psychology. Anxiety prolongs sleep latency by keeping the arousal system switched on at bedtime; depression fragments sleep architecture and produces early-morning waking; and the profound fatigue that many cancer patients describe, sometimes called lack of energy in supportive care research, is bidirectionally entangled with sleep, each worsening the other in a feedback loop. The fact that these associations held after adjustment suggests that sleep problems in young cancer patients are not an isolated symptom but part of a broader psychosocial burden. For clinicians, that means a patient who reports insomnia may be signaling anxiety or depression that has not yet been voiced, and conversely, a patient being treated for distress should be asked how they are sleeping.

The authors are careful about what the study can and cannot show. As an observational comparison, it cannot disentangle whether cancer and its treatments cause the sleep deficits, whether pre-existing vulnerabilities in some patients contribute to both poorer sleep and poorer coping with the disease, or whether the psychological consequences of a cancer diagnosis at a formative age drive the effect. The female predominance in the patient sample, at 75.2 percent, also limits generalizability, since sex differences in sleep are well documented. Still, the consistency of the deficits across five PSQI components, in a sample of more than 400 patients against a concurrent healthy group, gives the findings a weight that earlier single-arm studies lacked, and it aligns with the broader picture of AYA patients carrying a distinctive burden of health behavior risks and unmet supportive care needs.

The practical prescription that emerges from the AYA-LE data is disarmingly simple: ask. The authors conclude that sleep disturbances deserve greater attention in survivorship care and recommend routine assessment of sleep quality to identify AYA patients who could benefit from further evaluation and appropriate support. Routine screening with a tool as brief as the PSQI costs minutes, yet it could route young patients toward cognitive behavioral therapy for insomnia, evaluation of anxiety and depression, or targeted interventions for fatigue, rather than leaving them to self-medicate, as the elevated sleep medication use in this sample suggests many already do. As the population of adolescent and young adult cancer survivors continues to grow, the study argues that the question, how are you sleeping? may be one of the most clinically loaded questions an oncologist can ask.

Subject of Research: Sleep quality and disturbances in adolescents and young adults with cancer compared to healthy controls

Article Title: Sleep quality and disturbances in adolescents and young adults with cancer compared to a healthy comparison group: results of the AYA-LE study

Article References: Wieland, C., Friedrich, M., Sender, A., Leuteritz, K., Brock, H., Geue, K., Mehnert-Theuerkauf, A., & Richter, D. (2026). Sleep quality and disturbances in adolescents and young adults with cancer compared to a healthy comparison group: results of the AYA-LE study. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-026-06627-1

Image Credits: AI Generated

DOI: 10.1007/s00432-026-06627-1

Keywords: AYA cancer, sleep quality, PSQI, sleep disturbances, psycho-oncology, anxiety, depression, fatigue, survivorship care, quality of life, young adults, supportive care